title: Modulation of arachidonic Acid metabolism in the rat kidney by sulforaphane: implications for regulation of blood pressure.
abstract: Background. We investigated the effects of sulforaphane (SF), the main active isothiocyanate in cruciferous vegetables, on arachidonic acid (AA) metabolism in the kidney and its effect on arterial blood pressure, using spontaneously hypertensive rats (SHR) as models. Methods. Rats were treated for 8 weeks with either drinking water alone (control) or SF (20 or 40 mg/kg) added to drinking water. Mean arterial pressure (MAP) was measured at 7-day intervals throughout the study. At the end of treatment rats were euthanized, and kidneys were harvested to prepare microsomes and measure enzymes involved in regulation of vasoactive metabolites: CYP4A, the key enzyme in the formation of 20-hydroxyeicosatetraenoic acid, and the soluble epoxide hydrolase, which is responsible for the degradation of the vasodilator metabolites such as epoxyeicosatetraenoic acids. Effect of SF on kidney expression of CYP4A was investigated by immunoblotting. Results. We found that treatment with SF leads to significant reductions in both, the expression and activity of renal CYP4A isozymes, as well as the activity of soluble epoxide hydrolase (sEH). Consistent with these data, we have found that treatment with SF resisted the progressive rise in MAP in the developing SHR in a dose-dependent manner. Conclusion. This is the first demonstration that SF modulates the metabolism of AA by both P450 enzymes and sEH in SHR rats. This may represent a novel mechanism by which SF protects SHR rats against the progressive rise in blood pressure.
authors.affiliation: School of Pharmacy, Pacific University Oregon, 222 SE 8th Avenue, Hillsboro, OR 97123, USA.
authors.forename: Fawzy
authors.identifier: 0000-0002-5238-2712
authors.initials: F
authors.lastname: Elbarbry
authors.affiliation: Department of Integrative Biosciences, Oregon Health & Science University, Portland, OR 97239, USA ; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA.
authors.forename: Anke
authors.identifier: 0000-0003-3788-1406
authors.initials: A
authors.lastname: Vermehren-Schmaedick
authors.affiliation: Department of Integrative Biosciences, Oregon Health & Science University, Portland, OR 97239, USA.
authors.forename: Agnieszka
authors.identifier: 0000-0002-9317-1313
authors.initials: A
authors.lastname: Balkowiec
references.citation: J Clin Invest. 1999 Sep;104(6):751-60
references.pmid: 10491410
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10367-72
references.pmid: 9294217
references.citation: Circ Res. 1993 Jan;72(1):126-36
references.pmid: 8417836
references.citation: J Pharmacol Exp Ther. 1998 Jun;285(3):1327-36
references.pmid: 9618440
references.citation: Am J Physiol. 1996 Jan;270(1 Pt 2):R228-37
references.pmid: 8769806
references.citation: J Agric Food Chem. 2008 Nov 26;56(22):10505-9
references.pmid: 18950181
references.citation: Curr Opin Nephrol Hypertens. 2001 Jan;10(1):81-7
references.pmid: 11195057
references.citation: Am J Physiol. 1994 Feb;266(2 Pt 2):F275-82
references.pmid: 8141328
references.citation: Can J Physiol Pharmacol. 2001 Mar;79(3):266-82
references.pmid: 11294604
references.citation: Arch Biochem Biophys. 1996 Jun 1;330(1):87-96
references.pmid: 8651708
references.citation: Mol Pharmacol. 2000 May;57(5):1011-20
references.pmid: 10779386
references.citation: Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2455-65
references.pmid: 18952718
references.citation: J Clin Invest. 1994 Dec;94(6):2414-20
references.pmid: 7989598
references.citation: Cancer Res. 1975 Nov;35(11 Pt. 2):3326-31
references.pmid: 1104144
references.citation: Curr Drug Metab. 2003 Feb;4(1):73-84
references.pmid: 12570747
references.citation: J Biol Chem. 2013 Mar 15;288(11):7697-7703
references.pmid: 23362272
references.citation: Cancer Metastasis Rev. 2002;21(3-4):231-55
references.pmid: 12549763
references.citation: N Engl J Med. 2000 Jan 20;342(3):154-60
references.pmid: 10639540
references.citation: Nature. 1970 Aug 15;227(5259):680-5
references.pmid: 5432063
references.citation: J Biochem Mol Toxicol. 2007;21(1):41-50
references.pmid: 17366540
references.citation: Clin Immunol. 2009 Mar;130(3):244-51
references.pmid: 19028145
references.citation: Hypertension. 2003 Oct;42(4):548-54
references.pmid: 12939232
references.citation: J Biol Chem. 2000 Feb 11;275(6):4118-26
references.pmid: 10660572
references.citation: Hypertension. 2007 Mar;49(3):590-6
references.pmid: 17200437
references.citation: Physiol Rev. 2012 Jan;92(1):101-30
references.pmid: 22298653
references.citation: Am J Physiol. 1998 Feb;274(2):F395-404
references.pmid: 9486235
references.citation: Curr Opin Clin Nutr Metab Care. 2013 Jul;16(4):405-10
references.pmid: 23657153
references.citation: Am J Physiol Cell Physiol. 2002 Feb;282(2):C395-402
references.pmid: 11788351
references.citation: Physiol Rev. 2002 Jan;82(1):131-85
references.pmid: 11773611
references.citation: Am J Physiol Endocrinol Metab. 2011 Apr;300(4):E691-8
references.pmid: 21266668
references.citation: FASEB J. 1996 Nov;10(13):1456-63
references.pmid: 8940291
references.citation: FASEB J. 2006 Feb;20(2):371-3
references.pmid: 16354723
references.citation: Lancet. 1999 Aug 7;354(9177):447-55
references.pmid: 10465168
references.citation: Science. 1989 Jan 20;243(4889):388-90
references.pmid: 2492116
references.citation: J Hypertens. 2009 Oct;27(10):1948-54
references.pmid: 19587609
references.citation: Am J Hypertens. 2012 Feb;25(2):229-35
references.pmid: 22052072
references.citation: Proc Natl Acad Sci U S A. 1985 Dec;82(23):8232-6
references.pmid: 3934671
references.citation: Curr Drug Metab. 2004 Jun;5(3):245-56
references.pmid: 15180494
references.citation: Cell Mol Life Sci. 2007 May;64(9):1105-27
references.pmid: 17396224
references.citation: Proc Natl Acad Sci U S A. 2004 May 4;101(18):7094-9
references.pmid: 15103025
references.citation: Am J Hypertens. 2000 May;13(5 Pt 1):564-7
references.pmid: 10826412
references.citation: Am J Physiol. 1998 Aug;275(2):R426-38
references.pmid: 9688677
references.citation: J Neurosci Res. 2013 Feb;91(2):220-9
references.pmid: 23172808
references.citation: J Cardiovasc Pharmacol. 2000 May;35(5):763-8
references.pmid: 10813379
references.citation: J Biol Chem. 1951 Nov;193(1):265-75
references.pmid: 14907713